查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751112

2025年全球敗血症診斷市場報告

Sepsis Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計敗血症診斷市場規模將在未來幾年強勁成長。 2029年，該市場規模將成長至14.7億美元，複合年成長率為8.2%。預測期內的成長可歸因於對快速診斷日益成長的需求、醫療基礎設施投資的增加、對個人化醫療日益成長的關注、抗菌素抗藥性日益普遍以及次世代定序應用的不斷成長。預測期內預計的主要趨勢包括人工智慧在診斷中的整合、生物標記的技術進步、分子診斷的進展、向自動化和數位診斷平台的轉變以及診斷領域人工智慧的持續發展。

院內感染 (HAI) 發病率的上升預計將推動敗血症診斷市場的成長。 HAI 是指患者入住醫療機構期間或之後發生的感染疾病，通常發生在入院後 48 小時以上，且在入院時並不存在。 HAI 的增加主要是由於抗生素抗藥性問題日益嚴重。醫療環境中抗生素的過度使用和濫用導致了抗藥性細菌的產生，使感染疾病難以治療。敗血症診斷透過識別病原體和生物標記發揮關鍵作用，這些病原體和生物標記能夠及早發現院內感染，從而及時治療並減少併發症。例如，2024 年 11 月，澳洲健康與福利研究所報告稱，2022-2023 年，2% 的公立醫院入院患者和 0.8% 的私立醫院入院患者發生了醫院相關感染 (HAC)，其中 HAI 是最常見的併發症。因此，醫院內感染發生率的上升極大地推動了敗血症診斷市場的發展。

敗血症診斷市場的關鍵參與者正致力於開發創新解決方案，例如無需培養的診斷系統，該系統無需依賴傳統的血液培養即可快速準確地檢測敗血症。無需培養的診斷系統利用聚合酵素鏈鎖反應(PCR)、次世代定序(NGS) 和免疫測量等先進技術，直接從患者樣本（如血液、唾液和組織）中識別病原體。例如，2024 年 4 月，西班牙的 Deepull Diagnostics SL 推出了用於早期檢測敗血症的 UllCORE 診斷系統。這種無需培養的多重 PCR 平台能夠快速識別敗血症和其他急性感染疾病中的病原體。該系統從 8 毫升全血中提取微生物 DNA，並在一小時內提供 50 個可報告的結果。該系統可檢測出 95% 的敗血症致病原體，包括細菌、真菌和抗生素抗藥性基因，從而改善早期診斷並減少抗生素濫用，同時幫助醫院對抗抗菌素抗藥性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球敗血症診斷PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球敗血症診斷市場：成長率分析
  • 全球敗血症診斷市場表現：規模與成長，2019-2024
  • 全球敗血症診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球敗血症診斷總目標市場（TAM）

第6章市場區隔

  • 全球敗血症診斷市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 血培養基
  • 檢測套件和試劑
  • 軟體
  • 全球敗血症診斷市場（依技術、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 微生物學
  • 分子診斷
  • 免疫檢測
  • 流式細胞技術
  • 其他技術
  • 全球敗血症診斷市場（按病原體、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 細菌性敗血症
  • 黴菌性敗血症
  • 病毒性敗血症
  • 其他病原體
  • 全球敗血症診斷市場：依方法、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 自動診斷
  • 常規診斷
  • 全球敗血症診斷市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 病理學和參考實驗室
  • 研究機構
  • 全球敗血症診斷市場，依設備、產品細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 自動分析儀
  • 照護現場(POC) 設備
  • 基於微流體的設備
  • 聚合酵素鏈鎖反應（PCR）設備
  • 流式細胞儀
  • 全球敗血症診斷市場血液培養基細分（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 需氧血培養基
  • 厭氧血培養基
  • 結核分枝桿菌血培養基
  • 兒科血培養基
  • 黴菌血培養基
  • 全球敗血症診斷市場，按產品、性能和預測對檢測套件和試劑進行細分，2019-2024 年、2024-2029 年、2034 年
  • 酵素免疫分析法（ELISA）套件
  • 聚合酵素鏈鎖反應（PCR）檢測試劑套件
  • 免疫檢測
  • 分子診斷劑
  • 基於生物感測器的檢測試劑套件
  • 全球敗血症診斷市場軟體細分、產品、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 資料管理軟體
  • 實驗室資訊系統（LIS）
  • 基於人工智慧（AI）的診斷工具
  • 預測分析軟體
  • 雲端基礎的診斷平台

第7章 區域和國家分析

  • 全球敗血症診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球敗血症診斷市場：按國家、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 敗血症診斷市場：競爭格局
  • 敗血症診斷市場：公司簡介
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Becton, Dickinson and Company
  • Koninklijke Philips NV
  • GE Healthcare
  • Wolters Kluwer NV
  • bioMerieux SA
  • Bruker Corporation
  • DiaSorin SpA
  • Cepheid Inc.
  • Seegene Inc.
  • Luminex Corporation
  • T2 Biosystems Inc.
  • Cytovale Inc.
  • Accelerate Diagnostics Inc.
  • Immunexpress Inc.
  • Sepsis Alliance

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 敗血症診斷市場2029：提供新機會的國家
  • 敗血症診斷市場2029：細分市場帶來新機會
  • 敗血症診斷市場2029：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r34966

Sepsis diagnostics refers to a range of advanced technologies and tests designed to quickly detect the presence of sepsis, a critical condition that can lead to organ failure and death if not treated promptly. These diagnostic tools enable healthcare providers to assess the severity of sepsis and make timely, informed decisions to initiate appropriate treatments, ultimately improving patient survival rates.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main products in sepsis diagnostics include instruments, blood culture media, assay kits and reagents, and software. Instruments are medical devices used to rapidly analyze blood samples and detect pathogens, allowing for the early and accurate identification of sepsis and facilitating timely treatment. Sepsis diagnostics employ various technologies such as microbiology, molecular diagnostics, immunoassays, and flow cytometry to detect different types of pathogens, including bacterial, fungal, viral sepsis, and others. The diagnostic methods include both automated and conventional diagnostic approaches. These tools are used by various end-users, including hospitals and clinics, pathology and reference laboratories, and research institutes.

The sepsis diagnostics market research report is one of a series of new reports from The Business Research Company that provides sepsis diagnostics market statistics, including the sepsis diagnostics industry global market size, regional shares, competitors with the sepsis diagnostics market share, detailed sepsis diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the sepsis diagnostics industry. This sepsis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sepsis diagnostics market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.07 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing incidence of sepsis, growing awareness about the importance of early diagnosis, rising healthcare expenditure, a growing prevalence of hospital-acquired infections, and the increasing adoption of point-of-care testing.

The sepsis diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth during the forecast period can be attributed to the rising demand for rapid diagnostics, increasing investments in healthcare infrastructure, a growing focus on personalized medicine, the increasing prevalence of antimicrobial resistance, and the rising use of next-generation sequencing. Key trends expected in the forecast period include the integration of AI in diagnostics, technological advancements in biomarkers, progress in molecular diagnostics, a shift toward automated and digital diagnostic platforms, and the continued advancement of artificial intelligence in diagnostics.

The rising incidence of hospital-acquired infections (HAIs) is expected to drive growth in the sepsis diagnostics market. HAIs are infections that develop during or after a patient's stay in a healthcare facility, typically 48 hours or more after admission, and were not present at the time of admission. The increase in HAIs is largely due to the growing issue of antibiotic resistance. Overuse and misuse of antibiotics in healthcare settings have led to the development of resistant bacteria, making infections more difficult to treat. Sepsis diagnostics play a critical role by enabling early detection of hospital-acquired infections, identifying pathogens and biomarkers that allow for timely treatment and reduced complications. For instance, in November 2024, the Australian Institute of Health and Welfare reported that in 2022-2023, healthcare-associated infections (HACs) occurred in 2% of public hospital admissions and 0.8% of private hospital admissions, with HAIs being the most frequent complication. As a result, the rising incidence of hospital-acquired infections is significantly driving the sepsis diagnostics market.

Key players in the sepsis diagnostics market are focusing on the development of innovative solutions, such as culture-free diagnostic systems, to enable rapid and accurate detection of sepsis without relying on traditional blood cultures. Culture-free diagnostics leverage advanced technologies, including polymerase chain reaction (PCR), next-generation sequencing (NGS), or immunoassays, to identify pathogens directly from patient samples such as blood, saliva, or tissue. For example, in April 2024, Deepull Diagnostics S.L., a Spain-based company, launched the UllCORE diagnostic system for early sepsis detection. This culture-free, multiplex PCR platform provides rapid pathogen identification in sepsis and other acute infections. The system extracts microbial DNA from 8 mL of whole blood, offering 50 reportable results in just one hour. It detects 95% of sepsis-causing pathogens, including bacteria, fungi, and antibiotic resistance genes, helping hospitals combat antimicrobial resistance while improving early diagnosis and reducing antibiotic misuse.

In October 2024, Trinity Biotech plc, an Ireland-based medical laboratory company, acquired a 12.5% stake in Novus Diagnostics Ltd. for $2.5 million. This acquisition aims to accelerate the development and commercialization of Novus Diagnostics' rapid point-of-care diagnostic solutions, particularly its 15-minute bloodstream infection test. This rapid test is expected to significantly enhance sepsis diagnosis and improve patient outcomes by enabling faster and more accurate testing for bloodstream infections. Novus Diagnostics is an Ireland-based medical technology company developing diagnostic solutions for sepsis and other bloodstream infections.

Major players in the sepsis diagnostics market are Siemens Healthcare GmbH, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., GE Healthcare, Wolters Kluwer N.V., bioMerieux S.A., Bruker Corporation, DiaSorin S.p.A., Cepheid Inc., Seegene Inc., Luminex Corporation, T2 Biosystems Inc., Cytovale Inc., Accelerate Diagnostics Inc., Immunexpress Inc., Sepsis Alliance.

North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sepsis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sepsis diagnostics market consists of revenues earned by entities by providing services such as clinical consultation, rapid diagnostic testing solutions, point-of-care diagnostic solutions, biomarker testing, and molecular diagnostic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The sepsis diagnostics market also includes sales of sepsis diagnostic test kits, automated blood culture systems, molecular diagnostic equipment, sepsis biomarker assay kits, and rapid diagnostic devices for infection detection. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sepsis Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sepsis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sepsis diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Blood Culture Media; Assay Kits And Reagents; Software
  • 2) By Technology: Microbiology; Molecular Diagnostics; Immunoassays; Flow Cytometry; Other Technologies
  • 3) By Pathogen: Bacterial Sepsis; Fungal Sepsis; Viral Sepsis; Other Pathogens
  • 4) By Method: Automated Diagnostics; Conventional Diagnostics
  • 5) By End-Users: Hospitals And Clinics; Pathology And Reference Laboratories; Research Institutes
  • Subsegments:
  • 1) By Instruments: Automated Analyzers; Point-Of-Care (PoC) Testing Devices; Microfluidic-Based Devices; Polymerase Chain Reaction (PCR) Instruments; Flow Cytometers
  • 2) By Blood Culture Media: Aerobic Blood Culture Media; Anaerobic Blood Culture Media; Mycobacteria Blood Culture Media; Pediatric Blood Culture Media; Fungal Blood Culture Media
  • 3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Polymerase Chain Reaction (PCR) Assay Kits; Immunoassay Reagents; Molecular Diagnostic Reagents; Biosensor-Based Assay Kits
  • 4) By Software: Data Management Software; Laboratory Information Systems (LIS); Artificial Intelligence (AI)-Based Diagnostic Tools; Predictive Analytics Software; Cloud-Based Diagnostic Platforms
  • Companies Mentioned: Siemens Healthcare GmbH; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sepsis Diagnostics Market Characteristics

3. Sepsis Diagnostics Market Trends And Strategies

4. Sepsis Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sepsis Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sepsis Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sepsis Diagnostics Market Growth Rate Analysis
  • 5.4. Global Sepsis Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sepsis Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sepsis Diagnostics Total Addressable Market (TAM)

6. Sepsis Diagnostics Market Segmentation

  • 6.1. Global Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Blood Culture Media
  • Assay Kits And Reagents
  • Software
  • 6.2. Global Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microbiology
  • Molecular Diagnostics
  • Immunoassays
  • Flow Cytometry
  • Other Technologies
  • 6.3. Global Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Sepsis
  • Fungal Sepsis
  • Viral Sepsis
  • Other Pathogens
  • 6.4. Global Sepsis Diagnostics Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Diagnostics
  • Conventional Diagnostics
  • 6.5. Global Sepsis Diagnostics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Pathology And Reference Laboratories
  • Research Institutes
  • 6.6. Global Sepsis Diagnostics Market, Sub-Segmentation Of Instruments, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Analyzers
  • Point-Of-Care (Poc) Testing Devices
  • Microfluidic-Based Devices
  • Polymerase Chain Reaction (Pcr) Instruments
  • Flow Cytometers
  • 6.7. Global Sepsis Diagnostics Market, Sub-Segmentation Of Blood Culture Media, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aerobic Blood Culture Media
  • Anaerobic Blood Culture Media
  • Mycobacteria Blood Culture Media
  • Pediatric Blood Culture Media
  • Fungal Blood Culture Media
  • 6.8. Global Sepsis Diagnostics Market, Sub-Segmentation Of Assay Kits And Reagents, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (Elisa) Kits
  • Polymerase Chain Reaction (Pcr) Assay Kits
  • Immunoassay Reagents
  • Molecular Diagnostic Reagents
  • Biosensor-Based Assay Kits
  • 6.9. Global Sepsis Diagnostics Market, Sub-Segmentation Of Software, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Management Software
  • Laboratory Information Systems (Lis)
  • Artificial Intelligence (Ai)-Based Diagnostic Tools
  • Predictive Analytics Software
  • Cloud-Based Diagnostic Platforms

7. Sepsis Diagnostics Market Regional And Country Analysis

  • 7.1. Global Sepsis Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sepsis Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sepsis Diagnostics Market

  • 8.1. Asia-Pacific Sepsis Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sepsis Diagnostics Market

  • 9.1. China Sepsis Diagnostics Market Overview
  • 9.2. China Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sepsis Diagnostics Market

  • 10.1. India Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sepsis Diagnostics Market

  • 11.1. Japan Sepsis Diagnostics Market Overview
  • 11.2. Japan Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sepsis Diagnostics Market

  • 12.1. Australia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sepsis Diagnostics Market

  • 13.1. Indonesia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sepsis Diagnostics Market

  • 14.1. South Korea Sepsis Diagnostics Market Overview
  • 14.2. South Korea Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sepsis Diagnostics Market

  • 15.1. Western Europe Sepsis Diagnostics Market Overview
  • 15.2. Western Europe Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sepsis Diagnostics Market

  • 16.1. UK Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sepsis Diagnostics Market

  • 17.1. Germany Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sepsis Diagnostics Market

  • 18.1. France Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sepsis Diagnostics Market

  • 19.1. Italy Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sepsis Diagnostics Market

  • 20.1. Spain Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sepsis Diagnostics Market

  • 21.1. Eastern Europe Sepsis Diagnostics Market Overview
  • 21.2. Eastern Europe Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sepsis Diagnostics Market

  • 22.1. Russia Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sepsis Diagnostics Market

  • 23.1. North America Sepsis Diagnostics Market Overview
  • 23.2. North America Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sepsis Diagnostics Market

  • 24.1. USA Sepsis Diagnostics Market Overview
  • 24.2. USA Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sepsis Diagnostics Market

  • 25.1. Canada Sepsis Diagnostics Market Overview
  • 25.2. Canada Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sepsis Diagnostics Market

  • 26.1. South America Sepsis Diagnostics Market Overview
  • 26.2. South America Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sepsis Diagnostics Market

  • 27.1. Brazil Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sepsis Diagnostics Market

  • 28.1. Middle East Sepsis Diagnostics Market Overview
  • 28.2. Middle East Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sepsis Diagnostics Market

  • 29.1. Africa Sepsis Diagnostics Market Overview
  • 29.2. Africa Sepsis Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sepsis Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sepsis Diagnostics Market, Segmentation By Pathogen, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sepsis Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Sepsis Diagnostics Market Competitive Landscape
  • 30.2. Sepsis Diagnostics Market Company Profiles
    • 30.2.1. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Sepsis Diagnostics Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. Koninklijke Philips N.V.
  • 31.3. GE Healthcare
  • 31.4. Wolters Kluwer N.V.
  • 31.5. bioMerieux S.A.
  • 31.6. Bruker Corporation
  • 31.7. DiaSorin S.p.A.
  • 31.8. Cepheid Inc.
  • 31.9. Seegene Inc.
  • 31.10. Luminex Corporation
  • 31.11. T2 Biosystems Inc.
  • 31.12. Cytovale Inc.
  • 31.13. Accelerate Diagnostics Inc.
  • 31.14. Immunexpress Inc.
  • 31.15. Sepsis Alliance

32. Global Sepsis Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sepsis Diagnostics Market

34. Recent Developments In The Sepsis Diagnostics Market

35. Sepsis Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Sepsis Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sepsis Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sepsis Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34966_Sepsis_Diagnostics_GMR_2025